Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-09

Clinical Trial Update: Safety and Preliminary Efficacy of Organic Whole Psilocybin-Containing Mushrooms to Treat Patients Suffering From PTSD [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and preliminary efficacy of organic whole psilocybin-containing mushrooms for post-traumatic stress disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Organic Whole Psilocybin-Containing Mushrooms (psilocybin-containing mushrooms)

Snippet

Sponsor: Suzanne "Sue" Sisley MD | Conditions: PTSD | Phase 1 | Status: RECRUITING